Immunic
IMUX
IMUX
57 hedge funds and large institutions have $54.5M invested in Immunic in 2016 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
37% less capital invested
Capital invested by funds: $86.7M → $54.5M (-$32.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
57
Holding in Top 10
–
Calls
$423K
Puts
$166K
Top Buyers
| 1 | +$428K | |
| 2 | +$194K | |
| 3 | +$172K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$90.8K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$84K |
Top Sellers
| 1 | -$4.54M | |
| 2 | -$1M | |
| 3 | -$271K | |
| 4 |
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
|
-$152K |
| 5 |
Goldman Sachs
New York
|
-$140K |